A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.

Int J Surg Oncol · 2012 · PMC3362031 · PMID 22666572

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

a trend towards significanceP = 0.053so close (0.05 < p ≤ 0.1)

This was significant for noninferiority ( P = 0.0004) with a trend towards significance for superiority in favor of capecitabine ( P = 0.053) [ 32 ].

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.